Home › Funds › JOSH ARNOLD INVESTMENT CONSULTANT, LLC › TOI

JOSH ARNOLD INVESTMENT CONSULTANT, LLC position in TOI

STARLING ONCOLOGY INC

JOSH ARNOLD INVESTMENT CONSULTANT, LLC reported holding 2,493,109 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 10.11% of its reported portfolio and ranking #3 among its reported holdings. JOSH ARNOLD INVESTMENT CONSULTANT, LLC has disclosed TOI holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.49M sh
Reported value held$15.76M
Portfolio Weight10.11%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How JOSH ARNOLD INVESTMENT CONSULTANT, LLC's TOI position evolved

JOSH ARNOLD INVESTMENT CONSULTANT, LLC first disclosed a stake in TOI in Q3 2023 at 1,877,472 shares (US$2.6M). The position peaked in Q3 2026 at 2,493,109 shares, worth US$15.8M. Across 9 filings, JOSH ARNOLD INVESTMENT CONSULTANT, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,493,109 shares valued at US$15.8M — an increase of 28,750 shares quarter over quarter.. Notable position changes include a 92% trim in Q3 2025, a 1104% increase in Q4 2025.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.88M $2.65M New
Q4 2023 1.86M $3.79M Reduce
Q1 2025 1.99M $2.27M New
Q2 2025 2.45M $5.02M Add
Q3 2025 204.25K $712.83K Reduce
Q4 2025 2.46M $8.76M Add
Q1 2026 2.46M $7.57M Hold
Q2 2026 2.46M $13.38M Hold
Q3 2026 2.49M $15.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TOI and 13F data

TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$21.2M), WEXFORD CAPITAL LP (US$10.8M), BRC Group Holdings, Inc. (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TOI

All TOI fund holders →

FAQ

How long has JOSH ARNOLD INVESTMENT CONSULTANT, LLC held TOI?

JOSH ARNOLD INVESTMENT CONSULTANT, LLC has disclosed TOI holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is JOSH ARNOLD INVESTMENT CONSULTANT, LLC's current position in TOI?

As of Q3 2026, JOSH ARNOLD INVESTMENT CONSULTANT, LLC holds 2.49M shares of TOI (STARLING ONCOLOGY INC), valued at $15.76M, representing 10.11% of its reported portfolio and ranking #3.

Has JOSH ARNOLD INVESTMENT CONSULTANT, LLC been buying or selling TOI?

In the latest 13F filing (Q3 2026), JOSH ARNOLD INVESTMENT CONSULTANT, LLC increased its position in TOI. The position peaked in Q3 2026 at 2.49M shares.

Which other funds hold TOI?

Other major institutional holders of TOI include DEERFIELD MANAGEMENT COMPANY, L.P., WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.